Clinical Trial

ORASIS in Breast Reconstruction

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the use of ORASIS during microsurgical anastomosis formation in Deep Inferior Epigastric Perforator (DIEP) flap breast reconstruction and its potential effects on surgical precision, surgeon efficiency, and anastomosis outcomes. The investigators hypothesize that the use of ORASIS will decrease the amount of time needed to perform microsurgical anastomoses, reduce interruptions for irrigation and suction, and increase the quality of anastomoses in DIEP flap breast reconstruction.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-22.
Trial Details
NCT Number NCT07670754
Lead Sponsor Duke University
Conditions DIEP Flap, Breast Reconstruction, Breast Cancer
Enrollment 30 participants
Start Date 2026-12
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-01